Crinetics Pharmaceuticals (CRNX) Shares Issued (2017 - 2026)

Crinetics Pharmaceuticals' Shares Issued history runs 10 years deep, the most recent figure standing at $380.5 million for Q1 2026.

• In Q1 2026, Shares Issued changed N/A year-over-year to $380.5 million; the TTM figure through Mar 2026 stood at $371.9 million (down 37.38% YoY), while the FY2024 annual figure was $985.0 million, up 166.54% from the prior year.
• Shares Issued was $380.5 million for Q1 2026 at Crinetics Pharmaceuticals, up from -$14.6 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $543.5 million in Q4 2024 to a low of -$14.6 million in Q4 2025.
• Historically, Shares Issued has averaged $104.5 million across 5 years, with a median of $3.0 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Shares Issued soared 4235.71% in 2022, then sank 102.68% in 2025.
• A 5-year view of Shares Issued shows it stood at $112.6 million in 2022, then surged by 227.1% to $368.4 million in 2023, then surged by 47.52% to $543.5 million in 2024, then tumbled by 102.68% to -$14.6 million in 2025, then soared by 2710.55% to $380.5 million in 2026.
• The last three Shares Issued figures came in at $380.5 million (Q1 2026), -$14.6 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.